These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3084247)

  • 1. Correlation of predicted serum bactericidal activities and values measured in volunteers.
    Drusano G; Standiford H; Ryan P; McNamee W; Tatem B; Schimpff S
    Eur J Clin Microbiol; 1986 Feb; 5(1):88-92. PubMed ID: 3084247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The serum bactericidal activity of latamoxef (moxalactam), cefoperazone and cefotaxime.
    McNamee W; Drusano GL; Tatem BA; Standiford HC
    J Antimicrob Chemother; 1984 Nov; 14(5):491-7. PubMed ID: 6096348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of serum bactericidal activity after administration of cefoperazone, cefotaxime, ceftizoxime, and moxalactam to healthy subjects.
    Barriere SL; Ozasa DC; Mordenti J
    Antimicrob Agents Chemother; 1985 Jul; 28(1):55-7. PubMed ID: 3929680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum bactericidal activity of aztreonam, cefoperazone, and amikacin, alone or in combination, against Escherichia coli, Klebsiella pneumoniae, Serratia marcescens, and Pseudomonas aeruginosa.
    Van Laethem Y; Husson M; Klastersky J
    Antimicrob Agents Chemother; 1984 Aug; 26(2):224-7. PubMed ID: 6435515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum bactericidal activity of moxalactam and cefotaxime with and without tobramycin against Pseudomonas aeruginosa and Staphylococcus aureus.
    Lagast H; Zinner SH; Klastersky J
    Antimicrob Agents Chemother; 1981 Oct; 20(4):539-41. PubMed ID: 6282198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study of the serum bactericidal activity of cefoperazone alone and in combination with amikacin or mezlocillin against gram-negative bacilli and Staphylococcus aureus.
    Lagast H; Klastersky J; Standiford H; Viollier A
    Infection; 1984; 12(3):190-3. PubMed ID: 6432702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of desacetylcefotaxime and the interaction with its parent compound, cefotaxime.
    Oizumi K; Hayashi I; Aonuma S; Konno K
    Drugs; 1988; 35 Suppl 2():57-61. PubMed ID: 3135170
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum bactericidal activity of piperacillin/tazobactam against Staphylococcus aureus, piperacillin-susceptible and piperacillin-resistant Escherichia coli and Pseudomonas aeruginosa.
    Lemmen SW; Zolldann D; Klik S; Lütticken R; Kümmerer K; Häfner H
    Chemotherapy; 2004 Apr; 50(1):27-30. PubMed ID: 15084802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum bactericidal test in volunteers--a review.
    Schimpff SC; Drusano GL; Standiford HC
    Eur J Clin Microbiol; 1986 Feb; 5(1):71-8. PubMed ID: 3084246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bactericidal activity of ciprofloxacin in serum and urine against Escherichia coli, Pseudomonas aeruginosa, Klebsiella pneumoniae, Staphylococcus aureus and Streptococcus faecalis.
    Lagast H; Husson M; Klastersky J
    J Antimicrob Chemother; 1985 Sep; 16(3):341-7. PubMed ID: 2932416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative pharmacokinetics and serum bactericidal activities of SCE-2787 and ceftazidime.
    Paulfeuerborn W; Müller HJ; Borner K; Koeppe P; Lode H
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1835-41. PubMed ID: 8239592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary bactericidal activity, urinary excretion and plasma concentrations of gatifloxacin (400 mg) versus ciprofloxacin (500 mg) in healthy volunteers after a single oral dose.
    Boy D; Well M; Kinzig-Schippers M; Sörgel F; Ankel-Fuchs D; Naber KG
    Int J Antimicrob Agents; 2004 Mar; 23 Suppl 1():S6-16. PubMed ID: 15037323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefotaxime kinetics in plasma and synovial fluid following intravenous administration in horses.
    Orsini JA; Moate PJ; Engiles J; Norman T; Poppenga R; Benson CE; Boston RC
    J Vet Pharmacol Ther; 2004 Oct; 27(5):293-8. PubMed ID: 15500566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bactericidal activity of ciprofloxacin compared with that of cefotaxime in normal volunteers.
    Standiford HC; Drusano GL; Forrest A; Tatem B; Plaisance K
    Antimicrob Agents Chemother; 1987 Aug; 31(8):1177-82. PubMed ID: 3631942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the pharmacokinetics of ceftazidime and moxalactam and their microbiological correlates in volunteers.
    Drusano GL; Standiford HC; Fitzpatrick B; Leslie J; Tangtatsawasdi P; Ryan P; Tatem B; Moody MR; Schimpff SC
    Antimicrob Agents Chemother; 1984 Sep; 26(3):388-93. PubMed ID: 6391372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of newer beta-lactam agents in combination with amikacin against Pseudomonas aeruginosa, Klebsiella pneumoniae, and Serratia marcescens.
    Meyer RD; Pasiecznik K
    Diagn Microbiol Infect Dis; 1983 Dec; 1(4):287-93. PubMed ID: 6321092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro and in vivo studies of three antibiotic combinations against gram-negative bacteria and Staphylococcus aureus.
    Zinner SH; Klastersky J; Gaya H; Bernard C; Ryff JC
    Antimicrob Agents Chemother; 1981 Oct; 20(4):463-9. PubMed ID: 6282192
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem coadministered with cilastatin compared with moxalactam: integration of serum pharmacokinetics and microbiologic activity following single-dose administration to normal volunteers.
    Standiford HC; Drusano GL; Bustamante CI; Rivera G; Forrest A; Tatem B; Leslie J; Moody M
    Antimicrob Agents Chemother; 1986 Mar; 29(3):412-7. PubMed ID: 3459390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of concentration on bactericidal activity of cefotaxime.
    Shah PM; Troche G; Stille W
    J Antimicrob Chemother; 1979 Jul; 5(4):419-22. PubMed ID: 114510
    [No Abstract]   [Full Text] [Related]  

  • 20. [Microbiological evaluation of the antibacterial activity of cefotaxime in comparison with other cephalosporins].
    Concia E; Marone P; Verani D; Marino P
    Boll Ist Sieroter Milan; 1982; 61(4):300-8. PubMed ID: 6100233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.